Characterizing Deep Quality-of-Life Response in the TRuE-V1 TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo. J of Skin 2026, 10 (2), s752. https://doi.org/10.25251/bpnxm492.